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Taenia crassiceps, like other helminths, can exert regulatory eﬀects on the immune system of its host. This study investigates the
eﬀect of chronic T. crassiceps infection on the outcome of Multiple Low Dose Streptozotocin-Induced Diabetes (MLDS). Healthy
or previously T. crassiceps-infected mice received MLDS and type 1 diabetes (T1D) symptoms were evaluated for 6 weeks following
the induction of MLDS. T. crassiceps-infected mice displayed lower blood glucose levels throughout the study. A signiﬁcantly lower
percentageofT.crassiceps-infectedmice(40%)developedT1Dcomparedtotheuninfectedgroup(100%).Insulitiswasremarkably
absent in T. crassiceps-infected mice, which had normal pancreatic insulin content, whereas uninfected mice showed a dramatic
reduction in pancreatic insulin. Infected mice that received MLDS did not show an increase in their regulatory T cell population,
however, they had a greater number of alternatively activated macrophages, higher levels of the cytokine IL-4, and lower levels
of TNF-α. Therefore, infection with T. crassiceps causes an immunomodulation that modiﬁes the incidence and development of
MLDS-induced autoimmune diabetes.
1.Introduction
Parasitic helminths are a highly diverse group of organisms
that display diﬀerent morphologies, accessory structures,
sexual and feeding behaviors and life cycle stages. Helminths
distribute themselves across a variety of niches inside their
hosts where they can cause a multiplicity of diseases.
Helminth parasites also appear to follow varied and com-
plicated oral and cutaneous routes of infection within host
tissues. Surprisingly, despite these diﬀerences in features and
behavior, helminths share a unique ability to exert profound
regulatory eﬀects on the immune systems of their hosts.
One of the ﬁrst observations made concerning helminth
infection was the elicitation of a strong Th2-biased immune
response [1, 2]. In the last few years, new regulatory has been
identiﬁed to play a role in helminth infection [2, 3]. One
of these mechanisms includes the induction of regulatory
T cells (Tregs), which are now known to be involved in
pathogen susceptibility and the control of inﬂammation in
helminth infections caused by Litomosoides sigmodontis [4],
Trichuris muris [5], Brugia malayi [6], Trichinella spiralis
[7], and Heligmosomoides polygyrus [8]. Dendritic cells
(DCs) have also been reported to be aﬀected by helminth-
derived products [3, 9] and, more recently, a new population
of macrophages called alternatively activated macrophages
(AAMsφ) has been consistently observed in several worm
infection models [10, 11].
There are a series of epidemiological and experimen-
tal studies supporting the idea that helminth infections
can induce a protective eﬀect against the development of
both autoimmune and allergic diseases [12]. The “hygiene
hypothesis” was the ﬁrst to suggest that the increase in the
prevalence of allergies and asthma in developed countries
might be linked to the reduction in infections with parasitic
and bacterial pathogens. Thus, parasitic infection might
somehow“educate”theimmunesystemtoavoidexacerbated2 Journal of Biomedicine and Biotechnology
inﬂammatory responses [13, 14]. Type 1 diabetes (T1D)
is an autoimmune disease that has increased in prevalence
over the last several years in developed countries and is
caused by the selective destruction of insulin-producing β
cells located in pancreatic Langerhans’ islets by autoantigen-
reactive inﬂammatory T cells. When the majority of β cells
are destroyed, the pancreas’ ability to secrete insulin in
response to blood glucose levels is impaired, resulting in
a disruption of glucose homeostasis. Previous studies have
shown that the MLDS-induced diabetes model is a useful
tool for understanding the basic mechanisms associated
with the origin and modulation of induced T1D. T1D has
been correlated predominantly with genetic background as
well as proinﬂammatory cytokine proﬁles for TNF-α,I L - 1 2
and IFN-γ [15, 16]. For example, C57BL/6 mice are more
susceptible to developing MLDS-induced T1D than mice
lacking STAT-4, a transcription factor that is essential for IL-
12 signaling. STAT-4 deﬁcient mice have a delayed onset of
MLDS-induced T1D and show a milder form of the disease
[17].
Taenia crassiceps is a cestode parasite that is useful in
infection model systems for cysticercosis [18]. Infection of
inbred mice with T. crassiceps induces a strong Th2-like
immune response that is similar to the response elicited
by infection with other helminths [19]. In addition to this
Th2-like response, T. crassiceps infection is associated with a
series of immunomodulatory events including the induction
of AAMφ [20] and the inhibition of T cell proliferative
responses to bystander and polyclonal stimuli [2]. We and
others have found that infection with T. crassiceps alters
the immune response to and susceptibility to concomitant
pathogens such as Trypanosoma cruzi [21], vaccinia virus
[22], or Leishmania [18], and also reduces the eﬃcacy of
vaccination [23]. Thus, it is clear thatT. crassicepsinfection is
abletomodifyimmuneresponsestoconcomitantpathogens.
The purpose of this study is to determine whether
the immune modulation that is induced by T. crassiceps
infection might aﬀect the outcome of Multiple Low Dose
Streptozotocin-Induced Diabetes (MLDS). To address this
question, we compared the course of MLDS development in
bothhealthyandT.crassiceps-infectedmice.Ourdatasuggest
that T. crassiceps infection might modify the incidence and
development of MLDS-induced autoimmune diabetes.
2.MaterialsandMethods
2.1. Mice. Six- to eight-week-old male BALB/cAnN mice
and C57BL/6NHsd mice were purchased from Harlan Lab-
oratories (M´ exico) and were maintained in a pathogen-free
environment at the FES-Iztacala, U.N.A.M. animal facility in
accordance with institutional and national guidelines.
2.2. Parasites and Infection Protocols. Metacestodes of Taenia
crassiceps (ORF) were harvested in sterile conditions from
the peritoneal cavity of female BALB/c mice after 2–4
months of infection. The cysticerci were washed four times
in phosphate-buﬀered saline (PBS; 0.15MNaCl, 0.01M
sodium phosphate buﬀer, pH 7.2) and used for mouse infec-
tion. Male BALB/c and C57BL/6 mice were infected with
an intraperitoneal (i.p.) injection of 20 small, nonbudding
cysticerci of T. crassiceps resuspended in 0.3mL of PBS.
2.3. Multiple Low-Dose Streptozotocin-Induced Diabetes
(MLDS). Mice infected with T. crassiceps for 6 weeks or
uninfected controls received daily intraperitoneal injections
of 40mg/kg streptozotocin (Sigma-Aldrich; dissolved in
0.1M sodium citrate, pH 4.5) for 5 consecutive days. Blood
glucose was measured in animals that were fasted for 6 hours
by an Accu-chek Advantage glucometer (Roche Diagnostics)
o n c ep e rw e e ko v e ra6 - w e e kp e r i o d .U n t r e a t e dm i c ew e r e
included as controls. Animals were considered diabetic when
fasting blood glucose was greater than means ±2S Do nt w o
consecutive tests.
2.4. Intraperitoneal Glucose Tolerance Test. Uninfected and T.
crassiceps-infected mice were subjected to an intraperitoneal
glucose tolerance test in order to establish the eﬀects of the
MLDS-induced diabetes model on glucose metabolism (n =
6–10foreachgroup).UninfectedandinfectedMLDS-treated
mice were fasted for 6 hours prior to sample collection. A
basal blood sample (0 min) was collected by tail-snip and
plasma glucose was evaluated using an Accu-chek Advantage
glucometer. Mice were then injected i.p. with ﬁltered d-
glucose (1.5mg/kg). Glucose levels were evaluated again at
30-, 60-, and 120-minute time points.
2.5. Histology. Pancreata from C57Bl/6 and BALB/c mice
were collected 6 weeks after the induction of diabetes. Tissue
was processed and embedded in paraﬃn, and 5-μms e c t i o n s
were cut for histological analysis. Thin sections were stained
with hematoxylin-eosin and evaluated microscopically for
the presence of insulitis using the following scoring system:
grade 0, normal; grade 1, minor peri-islet cell inﬁltration;
g r a d e2 ,m o d e r a t ei n ﬁ l t r a t i o n( <50% of islet area); grade 3,
severe inﬁltration (>50% of islet area) with damage to islet
architecture.
2.6.Immunohistochemistry. Immunoperoxidasestainingwas
p e r f o r m e do n5 - μmp a r a ﬃn sections using an avidin-biotin
complex system, the Insulin Ab-6 (INS04 + INS05) mouse
monoclonal antibody, and the commercial kit Dako EnVi-
sion + System-HRP (DAB). Sections were counterstained
with hematoxylin. Images were captured using AxioVision
Rel 4.6An and an AxioCam ICc3 connected to a Zeiss
Microscope recorded the images.
2.7. Cytokine ELISAs. Peripheral blood was collected from
tail snips once a week over a 6-week period. Serum IL-4
and TNF-α levels were measured by sandwich ELISA using
commercial kits purchased from Peprotech (Rocky Hill, NJ,
USA).
2.8. Isolation of Peritoneal Macrophages. BALB/c and
C57BL/6 were sacriﬁced 6 weeks after induction diabetes.
Peritoneal exudate cells (PECs) from mice STZ, STZ/Tc, andJournal of Biomedicine and Biotechnology 3
Normal mice were obtained using 5mL of ice-cold sterile
PBS and the red blood cells were lysed by resuspending the
cells in Boyle’s solution. Following two washes, the viable
cells were counted by trypan blue exclusion with a Neubauer
hemocytometer. PECs were adjusted to 5 × 106/mL in
RPMI medium and then cultured in six-well plates (Costar,
Cambridge, Mass). After 2 hours at 37
◦C and in 5% CO2 ,
nonadherentcellswereremovedbywashingthemwithwarm
supplemented RPMI medium. Peritoneal macrophages were
aseptically removed and processed for RNA extraction using
the TRIzol reagent (Invitrogen, Carlsbad, CA).
2.9. Analysis of Cell Surface Markers in Macrophages. The Fc
receptorsonperitonealmacrophageswereblockedwithanti-
mouse CD16/CD32 (Biolegend, CA, USA) and then stained
with an APC-conjugated monoclonal antibody against F4/80
(Biolegend, CA, USA), PE-conjugated antibodies against
PD-L1 and PD-L2, FITC-conjugated antibodies against
CD23, or Alexaﬂuor-conjugated antimannose receptor anti-
body (all obtained from Biolegend). The stained cells were
analyzed on a FACsCalibur ﬂow cytometer using Cell Quest
software (Becton Dickinson).
2.10. T-Reg Cells Detection. Limph nodes were macerated
individually using frosted glass slides. The staining Treg cells
were according to the manufacturer instruction (Mouse Treg
Flow Kit, Biolegend).
2.11. Reverse Transcriptase-PCR. T o t a lR N Aw a se x t r a c t e d
from puriﬁed peritoneal macrophages obtained from
BALB/c and C57BL/6. mRNA transcripts in peritoneal
macrophages was determined by reverse transcription (RT)-
PCR. The RNA was quantiﬁed and 3mg of RNA were reverse
transcribedusingtheSuperscriptIIFirstStrandSynthesisKit
(Invitrogen) and an oligo dT primer, as recommended by the
manufacturer. Once cDNA was obtained, conventional PCR
was performed. The PCR reactions contained (in a 25mL
ﬁnalvolume)5 ×PCRbuﬀerblue,10mMdNTP,40nMeach
forward and reverse primer, 1 unit of Taq DNA polymerase
(Sacace Biotechnologies, Italy), and 2mL of the cDNA. The
program used for the ampliﬁcation of each gene was an
initial denaturation at 95 8◦C for 5 minutes, 35 cycles of
95 8◦C for 40 seconds, the indicated melting temperature
f o r5 0s e c o n d sa n d7 28 ◦C for 40 seconds and a ﬁnal
extension step of 72 8◦C for 4 minutes. All reactions were
carried out in a thermal cycler (Corbett Research, Australia).
Finally, to observe the ampliﬁed products, a 1.5% agarose
gel was prepared and samples were loaded with blue juice
buﬀer containing SYBR Green (Invitrogen). The gels were
visualized using a Fujiﬁlm FLA 5000 scanner (Fuji, Japan)
with FLA 5000 image reader V2.1 software to capture the
shown images.
2.12. Statistical Analysis. One-tail Student t-test (glycemia,
cytokine, and glucose tolerance test) was applied. P<. 05
was considered statistically signiﬁcant.
3. Results
3.1. Taenia crassiceps Infection Modulates Hyperglycemia and
Diabetes Incidence by Multiple Low Dose Streptozotocin-
Induced Diabetes. This study investigates whether T. cras-
siceps infection modiﬁes the onset and development of
MLDS-induced diabetes. Six weeks after infection with
T. crassiceps, male BALB/c and C57BL/6 mice received
MLDS (40mg/kg) for 5 consecutive days. Blood glucose
levels were analyzed each week for six weeks following the
treatment with MLDS. Uninfected BALB/c mice became
hyperglycemic one week post-MLDS injection (Figure 1(a)).
By the second week following the induction of diabetes
100% of the uninfected mice were diabetic and remained
diabetic until the end of the experimental period. In
contrast, T. crassiceps-infected BALB/c mice displayed signif-
icantly lower blood glucose levels throughout the six-week
period following MLDS injection compared to uninfected
mice (Figure 1(a)). Interestingly, the onset of diabetes (as
determined by glucose levels) was also diﬀerent between
uninfected and T. crassiceps-infected mice. The onset of
diabetes in T. crassiceps-infected BALB/c mice occurred 2
weeks after MLDS induction; whereas the onset of diabetes
occurred within the ﬁrst week following MLDS-induction
in uninfected mice. Additionally, only 40% of T. crassiceps-
infected mice developed hyperglycemia compared to 100%
in uninfected mice (Figure 1(b); P<. 05). Interestingly, T.
crassiceps-infected mice had normal glucose tolerance test
values (Figure 1(c)). In contrast, uninfected mice could not
down-modulate the hyperglycemia until 2 hours after the
glucose tolerance test was administered.
Ad i ﬀerent trend was observed in C57BL/6 mice.
C57BL/6 mice are known to be more susceptible to MLDS-
induced diabetes [24] and are more resistant to T. crassiceps
infection [25, 26]. C57BL/6 mice developed higher levels of
hyperglycemia than BALB/c mice, but these high glucose
levels were controlled after 4 weeks by T. crassiceps infection
(Figure 2(a)). Shortly after MLDS-induction, 80% of T.
crassiceps-infectedC57BL/6micewerediabetic(Figure 2(b)).
However, by 4 weeks following MLDS-induction infected
C57BL/6 mice began to recover from the hyperglycemia.
Only 20% of T. crassiceps-infected C57BL/6 mice were
diabetic at the end of this experiment. MLDS treatment
caused signiﬁcant elevations in glucose levels during an
intraperitoneal glucose tolerance test in uninfected mice,
but mice carrying T. crassiceps displayed normal glucose
tolerance test values (Figure 2(c)).
3.2. Lack of Insulitis in T. crassiceps Infected Mice Treated with
MLDS. It is known that MLDS stimulates the recruitment of
leukocytestopancreaticislets,resultingininsulitis[15].Pan-
creata were harvested at the end of the 6-week experimental
period for histopathological analysis. Figure 3 illustrates
islet histopathology and the development of insulitis in
uninfected and T. crassiceps-infected BALB/c and C57BL/6
mice. A signiﬁcant number of inﬁltrating leukocytes and
the presence of insulitis was observed in the pancreata from
uninfected mice (Figures 3(a) and 3(b)), which was associ-
ated with loss of islet architecture in some cases. Conversely,4 Journal of Biomedicine and Biotechnology
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Figure 1: Hyperglycemia and diabetes incidence is modiﬁed by T. crassiceps infection in BALB/c mice. (a) Blood glucose levels throughout
the MLDS protocol for uninfected BALB/c mice and BALB/c mice infected with T. crassiceps for 6 weeks. (b) Percent incidence of diabetes
between uninfected and T. crassiceps-infected BALB/c mice. (c) Intraperitoneal glucose tolerance test for MLDS-treated uninfected and T.
crassiceps-infected mice. Dotted line indicates normal glucose values.∗P<. 05, n = 12.
the islet histopathology from T. crassiceps-infected mice was
devoid of both cellular inﬁltrates and insulitis (Figures 3(a)
and 3(b)). Similar results were observed in the pancreata
from BALB/c and C57BL/6 mice.
3.3. Immunohistochemistry of Insulin in MLDS-Treated Mice.
To determine whether islet cells from either uninfected or T.
crassiceps-infected mice are able to produce insulin, we per-
formed speciﬁc immunostaining of pancreatic tissue using
an anti-insulin antibody. MLDS-treated T. crassiceps infected
micedemonstratedstronginsulinstainingintheirpancreatic
islets as compared with normal (untreated and uninfected)
mice (Figure 4(a)). In contrast, MLDS-treated uninfected
mice had weak insulin staining, suggesting a substantial
loss of insulin granules in islet β-cells. A similar result was
obtained from C57BL/6 mouse tissues (Figure 4(b)).
3.4. T. crassiceps Infection Increases IL-4 Levels in MLDS-
Treated Mice. To analyze whether the inhibition of diabetes
inhelminth-infectedMLDS-treatedmicewasduetoanalter-
ation in the Th1/Th2 balance, cytokine levels from the sera
of uninfected and infected mice were measured. The Th1-
associated cytokines IFN-γ and TNF-α have been reported
to accompany the development of diabetes in both NOD and
MLDS-induced mouse models [14, 27]. While BALB/c mice
did not show signiﬁcant changes in TNF-α levels in responseJournal of Biomedicine and Biotechnology 5
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Figure 2: Hyperglycemia and diabetes incidence is modiﬁed by T. crassiceps infection in C57BL/6 mice. (a) Blood glucose levels throughout
the MLDS protocol for uninfected C57BL/6 mice and mice infected with T. crassiceps for 6-weeks. (b) Percent incidence of diabetes between
uninfected and T. crassiceps-infected C57BL/6 mice. (c) Intraperitoneal glucose tolerance test for MLDS-treated uninfected and T. crassiceps-
infected mice. ∗P<. 05, n = 8.
to MLDS treatment (Figure 5(a)), uninfected C57BL/6J mice
hadhighlevelsofTNF-αandIFN-γ intheirsera(Figure 5(c),
and data not shown). Interestingly, C57BL/6 mice that were
previously infected with T. crassiceps and then treated with
MLDS displayed lower sera TNF-α levels but maintained ele-
vated levels of IFN-γ, as compared to uninfected mice (data
notshown).WealsoevaluatedtheeﬀectofT.crassicepsinfec-
tion on the presence of the Th2-associated cytokine IL-4. At
some experimental time points, IL-4 levels were signiﬁcantly
enhanced in both T. crassiceps-infected BALB/c and C57BL/6
mice that received MLDS whereas uninfected mice with T1D
had lower levels of serum IL-4 (Figures 5(c) and 5(d)).
3.5. Presence of AAMφ, but Not Tregs, in MLDS-Treated T.
crassiceps-Infected Mice. In the last few years, new classes of
regulatory cells that are induced by helminth infections have
been identiﬁed. Tregs and AAMφ have been implicated in
the control of immune pathology associated with helminth
infection, but both cell types have also been associated with
suppression of the immune response [28, 29]. In order to
determine whether these cells play a role in T. crassiceps-
mediated diabetes prevention, we performed FACS analysis
of peritoneal cells and T cells from the mesenteric lymph
node. Following MLDS treatment, neither uninfected nor T.6 Journal of Biomedicine and Biotechnology
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Figure 3: MLDS-mediated insulitis in BALB/c mice. All mice received MLDS for 5 consecutive days and were sacriﬁced 6 weeks later to
harvest tissues for histopathology. (a) H&E stained BALB/c mouse pancreas sections: normal islet, STZ (uninfected and MLDS-treated),
STZ/Tc (T. crassiceps-infected and MLDS-treated). (b) H&E stained C57BL/6 mouse pancreas sections. (c) Score of cell inﬁltrates in BALB/c
and C57BL/6 islets. Note the lack of leukocyte inﬁltrates in T. crassiceps-infected mice. Arrows indicate inﬁltration. Magniﬁcation ×400.
crassiceps-infected mice displayed an increase in the popu-
lation of Treg in the mesenteric lymph node (Figure 6(a)).
Interestingly,T.crassiceps-infectedmicedisplayedanincrease
inthepercentageofAAMφ intheperitoneum,asdetermined
by the expression of the mannose receptor, CD23, PDL1, and
MHCII (Figure 6(b)). To conﬁrm the presence of AAMφ,
RT-PCRwasperformedtodetectmRNAtranscriptsforFizz-
1 and PDL-1. These transcripts were present in peritoneal
cells from T. crassiceps-infected mice treated with MLDS, but
not in uninfected, MLDS-treated mice (Figure 6(c)).Journal of Biomedicine and Biotechnology 7
STZ STZ/Tc Normal
(a)
STZ STZ/Tc Normal
(b)
Figure 4: Insulin immunostaining of pancreatic islet cell from MLDS-treated mice. (a) Immunostaining of insulin in islets from BALB/c
mice, insulin immunostaining in pancreatic islets of diﬀerent uninfected (normal), uninfected and MLDS-treated mice (STZ), or T.
crassiceps-infected MLDS-treated mice (STZ/Tc). Mice (n = 4) were sacriﬁced 6 weeks after the initial injection of MLDS and pancreata
were processed for immunohistochemistry to speciﬁcally detect insulin. (b) Same as (a), just the sections belong to C57BL/6 mice. Note the
lack of insulin staining in uninfected MLDS-treated mice. Magniﬁcation ×400.
4. Discussion
T. crassiceps infection and its associated antigens can induce
Th2-type responses in vivo [20] and can modulate the
immuneresponsetobystanderantigensorliveinfections[2].
T. crassiceps, like other helminth parasites, has the ability to
manipulateanddown-modulatetheimmuneresponsesofits
hosts [10, 18]. It is widely accepted that the initiation and
development of T1D is mainly caused by an autoimmune
cell-mediated destruction of β cells in the pancreas [15].
Genetic, immunological, and environmental factors can
also inﬂuence the onset and development of T1D [30].
In this study, we found that T. crassiceps infection could
alter the development of MLDS-induced diabetes in mice.
This study demonstrates that T. crassiceps-infected mice
develop a mild, and sometimes transient, form of T1D after
MLDS treatment. In contrast, uninfected mice exhibited an
accelerated, more severe form of T1D.
There are likely several factors that contribute to the
protection by T. crassiceps infection against MLDS-induced
diabetes. First, the prominent Th2 environment that is
induced by T. crassiceps infection [19, 31]m i g h tc o u n t e r a c t
theproinﬂammatoryresponsesthatarenecessarytogenerate
complete MLDS-induced diabetes. Second, T. crassiceps
infection might alter T cell recruitment to the pancreas.
Third, T. crassiceps infection might induce a regulatory
cell response that dampens inﬂammatory processes during
MLDS-induced diabetes.
The ﬁndings of this study demonstrate that infection
with T. crassiceps maintains high levels of IL-4 and that there
is a slight reduction in serum TNF-α levels after infected
mice are treated with MLDS. TNF-α has been implicated as a
criticalplayerinleukocyte-mediatedisletdamage[32].Thus,
this type of immune regulation might be responsible for the
decrease in pathology and lower incidence of T1D observed
in T. crassiceps-infected mice. Consistent with a putative
protective role for Th2 type cytokines (IL-4), NOD mice that
express IL-4 in their pancreatic β cells are protected from
insulitis and autoimmune diabetes [33]. Other experimental
models have demonstrated that helminth exposure (Schisto-
soma mansoni, Trichinella spiralis, Hymenolepis diminuta or
Heligmosomoides polygyrus) to mice might drastically reduce
the symptoms of autoimmune diseases such as Inﬂamma-
tory Bowel Disease (IBD), Encephalomyelitis Autoimmune
Experimental, and T1D, mainly by reducing IL-12 and IFN-
γ production and enhancing IL-4 and IL-10 levels [34–
45]. Female NOD mice that spontaneously develop diabetes
due to Th1-mediated destruction of pancreatic β-cells are
protected from developing diabetes when they are exposed
to S. mansoni [34–36], and IL-4 has been shown to play an
important role in this protection [46, 47]. It will be necessary
to test our system in mice that either lack IL-4 or have been
treated with a speciﬁc IL-4 inhibitor to fully understand the
role that IL-4 plays in T. crassiceps protection against MLDS-
induced diabetes.8 Journal of Biomedicine and Biotechnology
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Figure 5: Cytokine proﬁles from the sera of mice treated with MLDS. BALB/c mice were bled at indicated time points and (a) TNF-α and
(b) IL-4 were detected by ELISA. (c) TNF-α and (d) IL-4 for C57BL/6 mice. ∗ P<. 05, n = 10.
We found that T. crassiceps infection resulted in an
increase in the population of F4/80+ macrophages that
express CD23, PDL1, MR, Arg1, Ym1, but not iNOS, an
expression proﬁle that is now used to identify AAMφ. AAMφ
might function as bystander suppressors of the immune
response. Alternatively, they might inhibit cell inﬁltration
in the pancreas, given their established suppressive activity,
which is mediated through cell-contact, where PD-L1 and
PD-L2 play a preponderant role, or by releasing soluble
factors [20]. In contrast, Treg cells were not detected in
T. crassiceps-infected mice. Mice that were infected with
T. crassiceps were protected from both hyperglycemia and
lymphocyte inﬁltration into the pancreatic islet despite the
absence of regulatory T cells. This is interesting given the
recent ﬁndings that demonstrate the importance of Foxp3+
regulatory T cell expansion in mice infected with helminths
[4–8]. Tregs induced by S. mansoni and its associated
antigens have been implicated in diabetes prevention in
NOD mice [36]. This discrepancy might be explained by
diﬀerences in the classes of helminths used in these infection
models, in the route of infection used, or by diﬀerent
suppressive mechanisms that are turned on by T. crassiceps
versus S. mansoni [11, 19]. Only one published report
demonstrates that macrophages are involved in preventing
the pathology associated with IBD model [48]. Therefore,
it is possible that AAMφ might actively participate in
dampening the pathology associated with MLDS-induced
diabetes, perhaps by the known ability of AAMφ to strongly
suppress T cell responses.
Interestingly, MLDS-induced diabetes is associated with
Th1-type responses [17] and C57BL/6 mice show a Th1-type
response in the MLDS model [24]. We also show that T.
crassiceps-infected C57BL/6 mice demonstrated a reversal of
MLDS-induced diabetes even though they were more hyper-
glycemic at earlier time points following MLDS-treatment.
Again, the speciﬁc regulatory cells and/or cytokines involved
in these protective eﬀects still need to be identiﬁed, however,
according to our data, appears that AAMφ it may have anJournal of Biomedicine and Biotechnology 9
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important role instead T-regulatory cells that we could not
detect in T. crassiceps-infected mice.
5. Conclusion
Our data support the notion that the protection from
autoimmunity by helminth infection could be attributed to
immunoregulatory mechanisms triggered by these parasites.
Our study demonstrates for the ﬁrst time that T. crassiceps
infectionprotectsagainstMultipleLowDoseStreptozotocin-
Induced Diabetes, independently of the genetic background
of the host. Furthermore, we present a possible protective
role for AAMφ since we did not detect enhanced Treg cells.
The analysis of Taenia-released products and repeating our
experiments under conditions of macrophage depletion will
be necessary to fully understand the mechanisms involved in
this observed protection.
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